Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Determinants of the use of insecticide-treated nets and intermittent preventive treatment of malaria among pregnant women in Angola
Aoki A. et al, (2025), International Health, 17, 934 - 941
Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood
Saito M. et al, (2025), Clinical Infectious Diseases
Retreatment or prolonged antiviral therapy in severe acute respiratory syndrome Coronavirus-2 infection among immunocompromised patients during 2022–2023: A nationwide claims-based cohort study in Japan
Yamamoto S. et al, (2025), Journal of Infection and Chemotherapy, 31, 102830 - 102830
Colonoscopy-Based Diagnosis of Dibothriocephalus nihonkaiensis Infection Protruding into the Ascending Colon
Adachi E. et al, (2025), The American Journal of Tropical Medicine and Hygiene, 113, 833 - 835
Comparative effectiveness of antiviral treatment on household transmission of SARS-CoV-2: a retrospective cohort study using administrative data
Ikeuchi K. et al, (2025), BMC Infectious Diseases, 25
A need for new tools for prevention of malaria in pregnancy
Saito M. and McGready R., (2025), PLOS Medicine, 22, e1004729 - e1004729
Use of Ursodeoxycholic Acid and the Risk of Severe Coronavirus Disease 2019 in Elderly Patients with Viral Hepatitis
Okushin K. et al, (2025), Internal Medicine, 64, 2301 - 2306
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs ex vivo
Sedohara A. et al, (2025), Frontiers in Microbiology, 16
Submicroscopic malaria in pregnancy and associated adverse pregnancy events: A case-cohort study of 4,352 women on the Thailand–Myanmar border
Gilder ME. et al, (2025), PLOS Medicine, 22, e1004529 - e1004529
MicroRNA in neuroexosome as a potential biomarker for HIV-associated neurocognitive disorders
Arizono K. et al, (2025), Journal of NeuroVirology, 31, 56 - 74
Clinical impact of the use of chronic suppressive antibiotics against recurrent ventricular assist device infections
Yamamoto S. et al, (2024), Microbiology Spectrum, 12
Hepatitis B Virus Reactivation After Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody
Adachi E. et al, (2024), Emerging Infectious Diseases, 30
Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017–2020
McGuire E. et al, (2024), Clinical Infectious Diseases, 78, 1443 - 1450
Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
Saito M. et al, (2024), Antimicrobial Agents and Chemotherapy, 68
Attenuation of hepatitis A antibody after immunization with hepatitis A vaccine (Aimmugen) in people living with HIV
Koga M. et al, (2024), Hepatology Research, 54, 487 - 494
Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022
Sedohara A. et al, (2024), Archives of Virology, 169
Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus Rilpivirine
Adachi E. et al, (2024), AIDS Research and Human Retroviruses, 40, 216 - 222
Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine
Adachi E. et al, (2024), AIDS Research and Therapy, 21
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
Uraki R. et al, (2023), iScience, 26, 108147 - 108147
Outbreaks of COVID-19 in a tuberculosis treatment sanatorium on the Thailand-Myanmar border: a retrospective cohort analysis
Aung HKK. et al, (2023), Wellcome Open Research, 8, 272 - 272